Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Open access
2,103
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
Sophie Marbaixa Global Health Economics, SNB Management, Soignies, Belgium;b Health Economics, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons–UMONS, Mons, BelgiumView further author information
, Nicolas Daubyc Department of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium;d School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgiumhttps://orcid.org/0000-0002-7697-6849View further author information
& Joaquin Mould-Quevedoe CSL Seqirus, Summit, NJ, USACorrespondence[email protected]
View further author information
View further author information
Pages 608-619
|
Received 30 Apr 2023, Accepted 22 Jun 2023, Published online: 04 Jul 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.